Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_assertion type Assertion NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_head.
- NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_assertion description "[The aim of this study was to determine if there is any difference in PML protein expression in breast cancer of BRCA1 and BRCA2 gene mutation carriers compared to sporadic breast cancer and if the PML protein can be used as a prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_provenance.
- NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_assertion evidence source_evidence_literature NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_provenance.
- NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_assertion SIO_000772 17822314 NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_provenance.
- NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_assertion wasDerivedFrom befree-2016 NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_provenance.
- NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_assertion wasGeneratedBy ECO_0000203 NP628816.RADxSP53f2bGbIgJFoFKnflvapK_Qu_LLEbp-81vx7wuw130_provenance.